A new study has found that opioid-related deaths are highest on the East Coast and opioids are affecting an increasing number of African-Americans.
New research has correlated the number of primary care physicians with population-level longevity. But, a shortage of primary care providers is forecast.
Rhode Island has instituted cost controls to limit the growth in health care spending. A Stanford analysis suggests they are effective.
The civil war in Yemen has led to an cholera epidemic and widespread starvation. Both were preventable, Stanford pediatrician Paul Wise says.
A new analysis found that the National Institutes of Health is funding more conservative research projects, which does not promote great new discoveries, the authors argue.
The U.S. Preventative Services Task Force encourages those who are at high risk of contracting HIV to take a daily pre-exposure drug.
Access and cost of insulin is affecting those who need it most, and without major improvements, millions will be without a treatment, a new study suggests.
Including price information in TV advertisements may lead consumers to avoid care or may misrepresent the actual cost of care, a Stanford scholar writes.
In this Q&A, Suhani Jalota, a graduate student in health policy, discusses her work helping impoverished women in India.
A Lancet commission has found that poor quality health care causes millions of unnecessary deaths; the worst deficits were found in vulnerable populations.
A study's comprehensive analysis reveals the indirect child casualties due to warfare in Africa; their deaths far outweigh direct warfare deaths.
The prevalence of suicide by firearm in the U.S. is just one of the many sobering statistics to emerge out of a new investigation of global gun violence.
Black men are more likely to get follow up care and to mention other health concerns after visiting a black doctor, a new Stanford study has found.
Most participants in clinical trials believe the benefits of broadly sharing individual data outweigh the risks, a new Stanford study has found.
A team of researchers has updated and improved the equations that guide prescribing decisions for physicians in the U.S. regarding cardiovascular risk.
The U.S. Preventive Services Task Force is now recommending that men aged 55 to 69 should talk with their doctors about prostate-specific antigen screening.